|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Article |
b Department of Infectious Diseases, 2300 RC Leiden University Medical Center (LUMC), 2300 RC, Leiden, The Netherlands
c The Department of Cell Biology and Histology, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands
d The Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., 702-8006 Okayama, Japan
e The Medical Research Council Centre for Immune Regulation, University of Birmingham, B9-555 Birmingham, United Kingdom
f The Immunology Division, Hacettepe University Children's Hospital, 06100 Ankara, Turkey
g Roche Milano Ricerche, I-20132 Milan, Italy
Department of Immunohematology and Blood Transfusion, LUMC, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands.31-71-521675131-71-5265128
t.h.m.ottenhoff{at}lumc.nl
Genetic lack of interleukin 12 receptor β1 (IL-12Rβ1) surface expression predisposes to severe infections by poorly pathogenic mycobacteria or Salmonella and causes strongly decreased, but not completely abrogated, interferon (IFN)-
Collectively, these results indicate that IL-12 acts as a partial agonist in the absence of IL-12Rβ1. Moreover, the results reveal the presence of a novel IL-12Rβ1/Stat4–independent pathway of IL-12 responsiveness in activated human T cells involving MAP kinases. This pathway is likely to play a role in the residual type 1 immunity in IL-12Rβ1 deficiency.
production. To study IL-12Rβ1–independent residual IFN-
production, we have generated mycobacterium–specific T cell clones (TCCs) from IL-12Rβ1–deficient individuals. All TCCs displayed a T helper type 1 phenotype and the majority responded to IL-12 by increased IFN-
production and proliferative responses upon activation. This response to IL-12 could be further augmented by exogenous IL-18. IL-12Rβ2 was found to be normally expressed in the absence of IL-12Rβ1, and could be upregulated by IFN-
. Expression of IL-12Rβ2 alone, however, was insufficient to induce signal transducer and activator of transcription (Stat)4 activation in response to IL-12, whereas IFN-
/IFN-
R ligation resulted in Stat4 activation in both control and IL-12Rβ1–deficient cells. IL-12 failed to upregulate cell surface expression of IL-18R, integrin
6, and IL-12Rβ2 on IL-12Rβ1–deficient cells, whereas this was normal on control cells. IL-12–induced IFN-
production in IL-12Rβ1–deficient T cells could be inhibited by the p38 mitogen-activated protein kinase (MAP) kinase inhibitor SB203580 and the MAP kinase kinase (MEK) 1/2 inhibitor U0126, suggesting involvement of MAP kinases in this alternative, Stat4-independent, IL-12 signaling pathway.
Key Words: mycobacteria Th1 interleukin 12 (receptor) interleukin 18 (receptor) interferon-
© 2000 The Rockefeller University Press
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|